INSIG1 and fatty liver disease: Among that, PCK1-mediated phosphorylation of INSIG1/2 could promote the activation of SREBP1 lipogenesis [37], and AQP9 could facilitate the hepatic uptake of glycerol and knockdown of the AQP9, thereby reducing hepatic steatosis [32].